Latest price-to-book ratio
Halozyme Therapeutics Price-to-book ratio
Direct answer
Halozyme Therapeutics's price-to-book ratio is 102.07x.
The verified market snapshot reports 102.07x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 27, 2026.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Price-to-book ratio
- 102.07x
Explore related company data
View Halozyme Therapeutics's market capitalizationView Halozyme Therapeutics's p/e ratioView Halozyme Therapeutics's return on equityView Halozyme Therapeutics's dividend yieldView Halozyme Therapeutics's 52-week price rangeView Halozyme Therapeutics's revenue growthView Halozyme Therapeutics's profit marginView Halozyme Therapeutics's debt-to-equity ratioView all Halozyme Therapeutics key metricsReturn to Halozyme Therapeutics profile